Perrigo Starting Shipments of Guaifenesin Extended-Release 600mgPerrigo Co. (Nasdaq: PRGO) Monday announced that it has begun shipments of Guaifenesin 600mg Extended-Release tablets in a launch to its retail and wholesale customers
Perrigo Launches Generic MucinexPerrigo Co. (Nasdaq: PRGO) announced that it has initiated shipments of its Guaifenesin Extended-Release Tablets, 600mg, a generic version of Mucinex 600mg tablets.
Perrigo Wins Summary Judgment in Generic Mucinex CasePerrigo Co. announced that the United States District Court for the Western District of Michigan has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex tablets.
Perrigo Receives Final FDA Approval For Store Brand Equivalent Of MucinexPerrigo Co. received final approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Guaifenesin Extended-Release Tablets, 600 mg.